M&T Bank Corp Medtronic PLC Call Options Transaction History

M&T Bank Corp

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$82.84 - $88.09 $662 - $704	8 Added 6.84%	125 $10,000
Q4 2023 Feb 06, 2024	SELL	$69.43 - $83.43 $902 - $1,084	-13 Reduced 10.0%	117 $9,000
Q3 2023 Nov 02, 2023	SELL	$78.22 - $90.4 $2,737 - $3,164	-35 Reduced 21.21%	130 $10,000
Q2 2023 Aug 09, 2023	BUY	$79.47 - $91.38 $3,099 - $3,563	39 Added 30.95%	165 $14,000
Q1 2023 May 11, 2023	BUY	$76.72 - $87.58 $9,666 - $11,035	126 New	126 $10,000

Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $4,199 - $4,956	52 Added 49.06%	158 $2,000
Q2 2022 Aug 05, 2022	SELL	$87.4 - $113.09 $1,048 - $1,357	-12 Reduced 10.17%	106 $1,000
Q1 2022 May 09, 2022	BUY	$100.58 - $112.38 $1,508 - $1,685	15 Added 14.56%	118 $14,000
Q4 2021 Feb 07, 2022	BUY	$99.53 - $127.75 $7,862 - $10,092	79 Added 329.17%	103 $1,000
Q3 2019 Nov 12, 2019	SELL	$98.02 - $111.18 $98 - $111	-1 Reduced 4.0%	24 $12,000
Q2 2019 Aug 12, 2019	BUY	$84.15 - $99.38 $84 - $99	1 Added 4.17%	25 $3,000
Q1 2019 May 15, 2019	BUY	$82.45 - $93.79 $1,236 - $1,406	15 Added 166.67%	24 $2,000
Q2 2017 Aug 11, 2017	BUY	N/A	9	9 $4,000

2,235

1.05B

6.1M

7.84M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $105B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.